Living Cell Technologies Limited (LCT) is a global pioneer in the field of cell encapsulation and implantation for human therapeutics.
LCT is a cell implant company, incorporated in Australia with operations in New Zealand, that is focused on developing living cell products for the treatment of diabetes and neurological diseases.
We have collaborations in Melbourne, Sydney, Auckland, Germany, Italy, Russia and the U.S.
LCT is internationally recognised for its research and development of therapies in disease areas that typically have no cure or poor treatment options. Our most advanced therapy, DIABECELL® for Type 1 diabetes is in Phase IIb trials. The lives of more than 20 million people with Type 1 diabetes may well change as preliminary clinical trial information has shown that two patients with long standing insulin dependent diabetes did not require daily insulin injections after treatment with DIABECELL for a period of up to 32 weeks after treatment. The majority of patients treated to date with low initial doses have shown improvement of diabetes control with better glycated haemoglobin (%HbA1c) levels.
The ground-breaking early results with DIABECELL demonstrate that LCT is at the forefront of technological advancements both in cell bioprocessing and cell encapsulation with its proprietary biocompatible alginate.
LCT is listed on the Australian Securities Exchange (ASX:LCT) and the US-based OTCQX (OTCQX:LVCLY).
LCT has more than 1800 shareholders from Australasia, Europe and the US and is working to further strengthen its international shareholder base.
LCT is committed to clear and transparent communication with its investors and adheres strictly to corporate governance guidelines.
updated 17th September, 2010
| © Copyright 1996-2013 irasia.com Ltd. All rights reserved. |
|
DISCLAIMER: irasia.com Ltd makes no guarantee as to the accuracy or completeness of any
information provided on this website. Under no circumstances shall irasia.com Ltd be liable
for damages resulting from the use of the information provided on this website.
TRADEMARK & COPYRIGHT: All intellectual property rights subsisting in the contents of this website belong to irasia.com Ltd or have been lawfully licensed to irasia.com Ltd for use on this website. All rights under applicable laws are hereby reserved. Reproduction of this website in whole or in part without the express written permission of irasia.com Ltd is strictly prohibited. TERMS OF USE: Please read the Terms of Use governing the use of our website. |